Chinese PE Multimodality Imaging Artificial Intelligence Study
Recruiting
Observational Study
Pulmonary Embolism
Chronic Thromboembolic Pulmonary Hypertension
Chronic Thromboembolic Pulmonary Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 14 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,500 (estimated)
- Sponsor
- China-Japan Friendship Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 14 Years and older
* Patients suspected of PE
Exclusion Criteria:
* Pregnant women
* Refuse to follow up
* Incomplete or discontinued imaging scans
* Insufficient quality of image data to allow for analysis
Contacts